Alessio Cortellini
@ACortelliniMD
Consultant Medical Oncologist-Asst. Professor @CampusBioMedico Rome (IT) and Honorary Clinical Lecturer @Imperial College London (UK).
Ozzy Osbourne is gone. Just a few days ago the farewell concert, absolute spine-tingling. He forged so many, changed the story of music. 🖤#RIP #PrinceOfDarkness
It is with more sadness than mere words can convey that we have to report that our beloved Ozzy Osbourne has passed away this morning. He was with his family and surrounded by love. We ask everyone to respect our family privacy at this time. Sharon, Jack, Kelly, Aimee and…
This never gets old 😅 It can be #ASCO, it can be #ESMO or #WCLC... Before and after... how on earth are we supposed to get back to clinic without a vacation to recover 😅 @DJPinato @thenasheffect @g_mountzios @Alfdoc2 @BRicciutiMD @DrJNaidoo
Hot off the press a 🚨 Must-read review on optimizing treatment for #LungCancer with activating EGFR mutations , a true game changer in targeted therapy. TKIs have transformed outcomes, but the journey continues. 👉 acsjournals.onlinelibrary.wiley.com/doi/full/10.33… thanks to all the co-authors, great team…
Activating mutations in EGFR gene has revolutionized management of #LungCancer, enabling development of TKIs. New review on strategies to optimize treatment: acsjournals.onlinelibrary.wiley.com/doi/full/10.33… @Alfdoc2 @Maxime_Borgeaud @Timothee_MD @JairBar4 @kaushalpar @jillfeldman4 @LeXiuning @OncoAlert
WOW, listening to @ChristianRolfo deliver an elegant lecture on liquid biopsy applications in #NSCLC in the timeless and magical setting of Erice, Sicily ... and in perfect Italian! 🇮🇹 @IASLC @isliquidbiopsy #Erice #Oncology #LiquidBiopsy
Steadfast commitment, great networking, a lot of effort, incredibly nice, truly one of a kind @AminNassarMD
👩🔬 Students, are you ready to elevate your research journey? Join #Curvia.org and connect with top mentors in oncology & tumor immunology. Research. Publish. Network. 🚀 📍 Sign up now at Curvia.org! #CancerResearch #Oncology #MedicalStudents #ResearchOpportunities
Honored to join the @IASLC Communications Committee for the 2025–2027 term! Excited to contribute to global thoracic oncology education and engagement. Looking forward to the journey ahead! #IASLC #LungCancer #WCLC2025
Proud of @GiuliaLaCavaMD for having led this effort! First first-author publication on the @ASCO educational book 💫 That's a good start 🇮🇹✨ @JuliaRotow @CampusBioMedico @PoliclinCampus
Our @ASCO review on #EGFR-positive NSCLC is out 🫁 A look at today’s landscape and tomorrow’s possibilities. Grateful to @ACortelliniMD @JuliaRotow & Jessica Bauman for their guidance and collaboration! ascopubs.org/doi/10.1200/ED…
I truly regret having missed @BRicciutiMD ’s talk on emerging biomarkers in early-stage #NSCLC at @ASCO, though I have no doubt it was outstanding! He is a force of nature: a brilliant scientist, an inclusive leader, and an admirable mentor 💫 @DFarberThoracic is lucky to have…
Dr. @BRicciutiMD of @DFarberThoracic discusses emerging biomarkers in the periop setting of #nsclc . Clip courtesy of @NarjustFlorezMD . @ASCO #ASCO25 #lcsm #lcam
Certainly agree with @JordiRemon that DELLI was a very brave study; it appears though that ultra-low dose of IO still provides OS benefit when compared to chemo in ≥ 2L. Masterful presentation as usual. #ASCO25 @ASCO #lcsm #lcam
Followed an entire session at #ASCO25 side by side with @HHorinouchi ! Such a pleasure to finally meet him in person! Best of luck for his new role on the @IASLC board of directors! 🫁👏 #LungCancer #ASCO25 #IASLC
This is truly a game changer for our patients with ES-SCLC! It's so rewarding seeing a great physicians scientist, friend and good-hearted person like @g_mountzios leading this effort! Also, nice to see Italy 🇮🇹 well-represented by @antoniolugini 👏💫
Congratulations to All the authors for this practice changing trial. Special shout out to @g_mountzios
Pleasure to see @MarcelloTiseo at #ASCO2025 presenting the ALNEO academic study by the @GOIRC2015 group and making the whole 🇮🇹 thoracic oncogy community proud! @ASCO @ALKpositiveINT
WAIT A MINUTE! we're all for science, research and networking, but I met #Milliethedog, officially appointed by @ASCO! She even has a badge🐶😍 Next session can wait, actually my #ASCO25 ends here, this is the cutest thing I've seen in years
So , #ASCO25 is about great science, excellent research, best care but also the colleagues and friends that you choose to be your second family !! #some #LCSM
Amazing talk by @thenasheffect in a packed Arie Crown Theater at #ASCO2025 on dll3/cd3 bispecifics, how #CRS and #ICANS can cluster and on potential biomarkers for neurotox! The bar has been raised and we need to learn how to deal with new tox @ASCO
🚨 New insights in #RETpositive #LungCancer: RET+ NSCLC often express MET & TROP2, moderately HER3 & EGFR, and rarely HER2. ➡️ Multiple membrane targets may co-exist 🧬 Dynamic changes post-treatment — fresh biopsy recommended 💡 Supports ADC & bispecific antibody trials…
Super proud of our own @valentsant for presenting her 1st @ASCO poster #ASCO25 on the value of PD-L1 in SqNSCLC, under the guidance of the stellar @BRicciutiMD 💫 @PoliclinCampus @CampusBioMedico
Honored to get the 2025 @oncodaily mentorship Yvonne Award from the one and only @PGrivasMDPhD. And in the presence of the crew that matters the most who came and supported! @AminNassarMD @SagalPannu @Ayeshaaijaz @BiagioRicciutMD @HMAbushukair @ACortelliniMD @msalmanfaisal
So proud of @thenasheffect on his award!!! #ASCO25
Thanks for sharing @jennifermarksmd !
New approaches in 1L mEGFR mutant NSCLC may lead to long-term survival gains. Very interesting data here. @ACortelliniMD @ASCO #ASCO25 #lcsm @EGFRResisters @DFEGFRcenter